BioWhittaker expands cell product line:
This article was originally published in Clinica
Executive Summary
BioWhittaker has added $1.4 million worth of cell culture product lines with the acquisition of VAI Diagnostics' cell cultures, including those for detection of herpesvirus, and liquid and powdered media for cell propagation from Hycor Biomedical.